Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin.

N-acetyl-L-methionine is a superior protectant of human serum albumin against post-translational oxidation as compared to N-acetyl-L-tryptophan. Biochem Biophys Rep (2016) 0.75

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem (2004) 15.51

Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem (1967) 12.40

Atomic structure and chemistry of human serum albumin. Nature (1992) 6.68

Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng (1999) 4.37

The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol (1975) 3.31

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci (2008) 3.16

Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol (2005) 3.00

Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal (1997) 2.77

Chemopreventive and therapeutic effects of curcumin. Cancer Lett (2004) 2.40

Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem (2007) 2.09

Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull (2002) 2.02

The extraordinary ligand binding properties of human serum albumin. IUBMB Life (2005) 2.00

A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res (2005) 1.85

Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis (2007) 1.78

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci U S A (2007) 1.52

Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob Agents Chemother (2006) 1.40

Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr Med Chem (2002) 1.38

Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull (2007) 1.24

Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic Biol Med (2003) 1.20

Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J Nutr Biochem (2008) 1.17

Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem J (2000) 1.10

Curcumin and its formulations: potential anti-cancer agents. Anticancer Agents Med Chem (2012) 1.08

Albumin-drug interaction and its clinical implication. Biochim Biophys Acta (2013) 1.06

Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochim Biophys Acta (1996) 1.04

Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. Biochem J (2001) 0.95

Metal-catalyzed oxidation of human serum albumin: conformational and functional changes. Implications in protein aging. J Biol Chem (1991) 0.95

Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands. Mol Pharmacol (1988) 0.89

Oxidation of Arg-410 promotes the elimination of human serum albumin. Biochim Biophys Acta (2006) 0.88

Effect of oxidative stress on the structure and function of human serum albumin. Pharm Res (2001) 0.87

Differential antioxidant/pro-oxidant activity of dimethoxycurcumin, a synthetic analogue of curcumin. Free Radic Res (2011) 0.84

Study of curcumin and genistein interactions with human serum albumin. J Pharm Biomed Anal (2008) 0.84

Curcuminoids rescue long-term potentiation impaired by amyloid peptide in rat hippocampal slices. Synapse (2010) 0.84

In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa. Phytother Res (2003) 0.84

Interaction of curcumin with human serum albumin--a spectroscopic study. Lipids (1999) 0.84

Spectroscopic techniques in the study of protein binding: the use of 1-anilino-8-naphthalenesulphonate as a fluorescent probe for the study of the binding of iophenoxic and iopanoic acids to human serum albumin. Mol Pharmacol (1973) 0.83

Characterization of the benzodiazepine binding site (diazepam site) on human serum albumin. Chem Pharm Bull (Tokyo) (1985) 0.79

Unique, pH-dependent biphasic band shape of the visible circular dichroism of curcumin-serum albumin complex. Biochem Biophys Res Commun (2003) 0.77

Analysis of binding interaction of curcumin and diacetylcurcumin with human and bovine serum albumin using fluorescence and circular dichroism spectroscopy. Protein J (2009) 0.77

Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin. Biochem Pharmacol (1991) 0.77

Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin. PLoS One (2017) 0.75